크립토텐시논을 유효성분으로 함유하는 세포성장 조절제조성물
    3.
    发明公开
    크립토텐시논을 유효성분으로 함유하는 세포성장 조절제조성물 无效
    含有CRYPTOTANSHINONE作为活性成分的细胞生长调节剂组合物

    公开(公告)号:KR1020020007014A

    公开(公告)日:2002-01-26

    申请号:KR1020000040668

    申请日:2000-07-14

    Abstract: PURPOSE: Provided is a cell growth regulator composition containing cryptotanshinone as active ingredient. Particularly, the cryptotanshinone has an excellent selective inhibition effect on cyclin dependent kinas 4(CDK4) and is thus used for drug preparations for the treatment and prevention of various diseases. CONSTITUTION: The cell growth regulator composition characteristically contains Cryptotanshinone represented by the formula(1) selectively inhibiting the activity of CDK4/cyclin D and a pharmaceutically acceptable carrier. It inhibits the cell growth and is thus ultimately used in developing drug preparations for the prevention and treatment of various diseases caused by abnormal cell cycle.

    Abstract translation: 目的:提供含有隐丹参酮作为活性成分的细胞生长调节剂组合物。 特别地,隐丹参酮对细胞周期蛋白依赖性激酶4(CDK4)具有优异的选择性抑制作用,因此用于治疗和预防各种疾病的药物制剂。 构成:细胞生长调节剂组合物特征性地含有由式(1)表示的隐丹参酮选择性抑制CDK4 /细胞周期蛋白D的活性和药学上可接受的载体。 它抑制细胞生长,因此最终用于开发用于预防和治疗由异常细胞周期引起的各种疾病的药物制剂。

    신규의 항진균 물질 KRF-001 복합체의 발효 및 정제방법
    4.
    发明授权
    신규의 항진균 물질 KRF-001 복합체의 발효 및 정제방법 失效
    新型抗真菌物质KRF-001复合物的发酵纯化方法

    公开(公告)号:KR1019930001870B1

    公开(公告)日:1993-03-18

    申请号:KR1019900017552

    申请日:1990-10-31

    Abstract: Biologically pure cultures of Bacillus subtilis sub sp. Krictiensis (ATCC 55079) and of its mutant M18-91 (ATCC 55078) are new. The new microorganisms produce the antifungal complex KRF-001 (disclosed as new but not claimed) which is useful as an agricultural or therapeutic fungicide, food presevative or skin moisturiser. It has a broad spectrum of activity and low toxicity.

    Abstract translation: 枯草芽孢杆菌属的生物纯培养物 Krictiensis(ATCC 55079)及其突变体M18-91(ATCC 55078)是新的。 新的微生物产生可用作农业或治疗杀真菌剂,食品预防剂或皮肤保湿剂的抗真菌复合物KRF-001(公开为新的但未被要求保护)。 它具有广泛的活性和低毒性。

Patent Agency Ranking